In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematosus

Arthritis and Rheumatism

Volumn 40, Issue 5, 1997, Pages 814-821

  Denfeld, Ralf W ^a   Kind, Peter ^b   Sontheimer, Richard D ^c   Schöpf, Erwin ^a   Simon, Jan C ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN;

ANTIGEN PRESENTING CELL; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISCOID LUPUS ERYTHEMATOSUS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BIOPSY; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 0030904858     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400507     Document Type: Article

References (39)

1. David-Bajar KM: Subacute cutaneous lupus erythematosus. J Invest Dermatol 100:2S-8S, 1993
2. Honwitz DA, Stohl W: T lymphocytes, cytokines and immune regulation in systemic lupus erythematosus. In, Dubois' Lupus Erythematosus. Twenty-fourth edition. Edited by DJ Wallace, BH Hahn. Philadelphia, Lea & Febiger, 1993
3. Dayal AK, Kammer GM: The T cell enigma in lupus. Arthritis Rheum 36:23-33, 1996
4. June CH, Bluestone JA, Nadler LM, Thompson CB: The B7 and CD28 receptor families. Immunol Today 15:321-331, 1994
5. Linslcy PS: Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation? J Exp Med 182:289-292, 1995
6. Linsley PS, Greene JL, Brady W, Bajorath J, Ledbetter JA, Peach R: Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1:793-801, 1994
7. Linsley PS, Ledbetter JA: The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 11:191-212, 1993
8. Boussiotis VA, Freeman GJ, Gribben JG, Daley J, Gray GS, Nadler LM: Activated human B lymphocytes express three CTLA-4 binding counterreceptors which costimulate T cell activation. Proc Natl Acad Sci U S A 90:11059-11063, 1993
9. Augustin M, Dietrich A, Niedner R, Kapp A, Schöpf E, Ledbetter JA, Brady W, Linsley PS, Simon JC: Phorbol-12-myristate-13acetate-treated human keratinocytes express B7-like molecules that serve a costimulatory role in T cell activation. J Invest Dermatol 100:275-281, 1993
10. Fleming TE, Mirando WS, Trefzer U, Tubesing KA, Elmets CA: In situ expression of a B7-like adhesion molecule on keratinocytes from human epidermis. J Invest Dermatol 101:754-758, 1993
11. Nickoloff BJ, Mitra RS, Lee K, Turka LA, Green J, Thompson CB, Shimizu Y: Discordant expression of CD28 ligands, BB-1, and B7 on keratinocytes in vitro and on psoriatic cells in vivo. Am J Pathol 142:1029-1040, 1993
12. Nasir A, Ferbel B, Gaspari AA: Human keratinocytes regulate their expression of B7/BB-1 antigen by a unique, calcium-dependent mechanism. J Invest Dermatol 104:763-767, 1995
13. Lanier LL, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D, Azuma M: CD80 (B7) and CD86 (B70) provide similar signals for T cell proliferation, cytokine production, and generation of CTL J Immunol 154:97-105, 1995
14. Boussiotis VA, Freeman GJ, Gray GS, Gribben JG, Nadler LM: B7 but not ICAM-1 costimulation prevents the induction of human alloantigen-specific tolerance. J Exp Med 178:1753-1763, 1993
15. Gimmi CD, Freeman GJ, Gribben JG, Gray GS, Nadler LM: Human T cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation, Proc Natl Acad Sci U S A 90:6586-6590, 1993
16. Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP: CD28-mediated signalling costimulates murine T cells and prevents induction of anergy in T cell clones. Nature 356:607-609, 1992
17. Tan P, Anasetti C, Hansen JA, Melrose J, Brunvard M, Bradshaw J, Ledbetter JA, Linsley PS: Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB-1. J Exp Med 177:165-173, 1993
18. Blazar BR, Taylor PA, Linsley PS, Vallera PA: In vivo blockade of CD28/CTLA-4: B7/BB-1 interaction with CTLA-4Ig reduces lethal murine graft versus host disease across the major histocompatibility complex barrier in mice. Blood 83:3815-3825, 1994
19. Guerder S, Meyerhoff J, Flavell R: The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. Immunity 1:155-166, 1994
20. Harlan DM, Hengartner H, Huang ML, Kang YH, Abe R, Moradith RW, Pircher H, Gray GS, Ohashi PS, Freeman GJ, Nadler LM, June CH, Aichele P: Mice expressing both B7-1 and viral glycoprotein on pancreatic β cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T lymphocyte unresponsiveness. Proc Natl Acad Sci U S A 91:3137-3141, 1994
21. Lenschow DJ, Zeng Y, Thistlethwaite JR, Montag A, Brady W, Gibson MG, Linsley PS, Bluestone JA: Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA-4Ig. Science 257:789-792, 1992
22. Lin H, Boiling SF, Linsley PS, Wei RQ, Gordon D, Thompson CB, Turka LA: Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA-4Ig plus donor-specific transfusion. J Exp Med 178:1801-1806, 1993
23. Linsley PS, Wallace PM, Johnson J, Gibson MG, Greene JL, Ledbetter JA, Singh C, Tepper MA: Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257:792-795, 1992
24. Finck BK, Linsley PS, Wofsy D: Treatment of murine lupus with CTLA-4Ig. Science 265:1225-1227, 1994
25. Alvarado C, Alcocer-Varela J, Llorente L, Richaud-Patin Y, Cerbon M, Alarcon-Segovia D: Effect of CD28 antibody on T cells from patients with systemic lupus erythematosus. J Autoimmun 7:763-773, 1994
26. Sfikakis PP, Oglesby R, Sfikakis P, Tsokos GC: B7/BB-1 provides an important costimulatory signal for CDS-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 96:8-14, 1994
27. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982
28. Simon JC, Dietrich A, Mielke V, Wuttig C, Vanscheidt W, Linsley PS, Schöpf E, Sterry W: Expression of the B7/BB-1 activation antigen and its ligand CD28 in T-cell-mediated skin diseases. J Invest Dermatol 103:539-543, 1994
29. Denfeld RW, Dietrich A, Wuttig C, Tanczos E, Weiss JM, Vanscheidt W, Schöpf E, Simon JC: In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T cell mediated antitumor immunity. Int J Cancer 62:259-265, 1995
30. García-Cózar FJ, Molina IJ, Cuadrado MJ, Marubayashi M, Peña J, Santamaría M: Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus patients. Clin Exp Immunol 104:72-79, 1996
31. Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray G, Nabavi N, Herold KC, Bluestone JA: Differential effects of anti-B7-l and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 181:1145-1155, 1995
32. Kuchroo VK, Prabhu Das M, Brown JA, Ranger AM, Zamvil SS, Sobcl RA, Weiner HL, Nabavi N, Glimcher LH: B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707-718, 1995
33. Perrin PJ, Scott D, Quigley L, Albert PS, Feder O, Gray GS, Abe R, June CH, Racke MK: Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J Immunol 154:1481-1490, 1995
34. Nakajima A, Azuma M, Kodera S, Nuriya S, Terashi A, Abe M, Hirose S, Shirai T, Yagita H, Okumura K: Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule. Eur J Immunol 25:3060-3069, 1995
35. Freeman GJ, Boussiotis VA, Anumanthan A, Bernstein GM, Ke X-Y, Rennert PD, Gray GS, Gribben JG, Nadler LM: B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2:523-532, 1995
36. Nickoloff BJ, Turka LA: Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol Today 15:464-469, 1994
37. Gaspari AA, Ferbel B, Chen Z, Razvi F, Polakowska R: Accessory and alloantigen-presenting cell functions of A431 keratinocytes that stably express the B7 antigen. Cell Immunol 149:291-302, 1993
38. Williams IR, Ort RJ, Kupper TS: Keratinocyte expression of B7-1 in transgenic mice amplifies the primary immune response to cutaneous antigens. Proc Natl Acad Sci U S A 91:12780-12784, 1994
39. Gajewski TF, Lancki DW, Stack R, Fitch FW: "Anergy" of Th0 helper T lymphocytes induces downregulation of Th1 characteristics and a transition to a Th2 phenotype. J Exp Med 179:481-491, 1994